Search Results - "Dahlen, Jeffrey R"
-
1
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
Published in Thrombosis and haemostasis (01-10-2019)“…Various antithrombotic agents are clinically used to inhibit the cascade of arterial or venous thrombosis in cardiovascular diseases. Dual antiplatelet therapy…”
Get more information
Journal Article -
2
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
Published in Journal of clinical & translational endocrinology (01-06-2020)“…HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated…”
Get full text
Journal Article -
3
Early Biomarkers of Stroke
Published in Clinical chemistry (Baltimore, Md.) (01-10-2003)“…The diagnosis and management of acute ischemic stroke are limited by the lack of rapid diagnostic assays for use in an emergency setting. Computed tomography…”
Get full text
Journal Article -
4
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases
Published in Critical care explorations (01-03-2023)“…Early detection of illness trajectory in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients is crucial for patients and healthcare…”
Get full text
Journal Article -
5
Differential inhibition of platelet function by cilostazol in combination with clopidogrel
Published in European journal of clinical pharmacology (01-12-2023)“…Purpose To assess the antiplatelet effect of cilostazol clinically, we compared the effects of cilostazol in combination with clopidogrel on various platelet…”
Get full text
Journal Article -
6
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19
Published in Open forum infectious diseases (01-07-2021)“…Abstract Urine 11-dehydro-thromboxane B2 (u11-dh-TxB2), 8-hydroxy-2’-deoxyguanosine (8-OHdG), and liver-type fatty acid binding protein levels (L-FABP) at the…”
Get full text
Journal Article -
7
1227-P: GlycoMark 1,5-Anhydrocluitol Values in Patients Taking SGLT2 Inhibitors
Published in Diabetes (New York, N.Y.) (01-06-2019)“…The GlycoMark test measures 1,5-anhydroglucitol (1,5-AG), which is an indicator of hyperglycemic excursions over the prior 1-2 weeks in patients with diabetes…”
Get full text
Journal Article -
8
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists
Published in Current problems in cardiology (01-09-2021)“…Contrast-induced acute kidney injury (CI-AKI) occurs in up to 10% of cardiac catheterizations and coronary interventions, resulting in increased morbidity,…”
Get full text
Journal Article -
9
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures
Published in Cardiorenal medicine (2022)“…Introduction: Contrast-induced acute kidney injury (CI-AKI) is a major clinical complication of percutaneous cardiovascular procedures requiring iodinated…”
Get full text
Journal Article -
10
ANTARCTIC: platelet function testing to adjust therapy
Published in The Lancet (British edition) (25-03-2017)“…In the GENERATIONS2 and TRILOGY ACS3 trials, the bleeding rates were the same between the prasugrel 5 mg and clopidogrel 75 mg groups. [...]the ANTARCTIC…”
Get full text
Journal Article -
11
Variation in Diabetes Management: A National Assessment of Primary Care Providers
Published in Journal of diabetes science and technology (01-01-2020)“…Background: Glucose control is monitored primarily through ordering HbA1c levels, which is problematic in patients with glycemic variability. Herein, we report…”
Get full text
Journal Article -
12
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y(12) antagonism
Published in Platelets (Edinburgh) (2011)“…The VerifyNow® P2Y12 (VN-P2Y12) test reports thienopyridine-mediated platelet inhibition relative to a "BASE" channel, potentially eliminating the need for…”
Get full text
Journal Article -
13
Inhibition of Soluble Recombinant Furin by Human Proteinase Inhibitor 8
Published in The Journal of biological chemistry (23-01-1998)“…Furin is a ubiquitous prototypical mammalian kexin/subtilisin-like endoproteinase that is involved in the proteolytic processing of a variety of proteins in…”
Get full text
Journal Article -
14
Molecular Cloning, Expression, and Partial Characterization of Two Novel Members of the Ovalbumin Family of Serine Proteinase Inhibitors(∗)
Published in The Journal of biological chemistry (15-12-1995)“…A human placental λgt11 cDNA library was screened for sequences encoding proteins related to human proteinase inhibitor 6 (PI6), and two plaques were…”
Get full text
Journal Article -
15
Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9
Published in Biochimica et biophysica acta (21-09-1999)“…Proteinase inhibitor PI9 (PI9) is an intracellular 42-kDa member of the ovalbumin family of serpins that is found primarily in placenta, lung and lymphocytes…”
Get full text
Journal Article -
16
Expression, Purification, and Inhibitory Properties of Human Proteinase Inhibitor 8
Published in Biochemistry (Easton) (02-12-1997)“…In a previous report, the cDNA for human proteinase inhibitor 8 (PI8) was first identified, isolated, and subcloned into a mammalian expression vector and…”
Get full text
Journal Article -
17
Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measures
Published in Thrombosis and haemostasis (01-05-2013)“…Various diagnostic and prognostic performance measures have been used to describe the clinical usefulness of platelet function testing in the evaluation and…”
Get more information
Journal Article -
18
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y12 antagonism
Published in Platelets (Edinburgh) (01-12-2011)“…The VerifyNow® P2Y12 (VN-P2Y12) test reports thienopyridine-mediated platelet inhibition relative to a "BASE" channel, potentially eliminating the need for…”
Get full text
Journal Article -
19
A Unique and Comprehensive Approach to Quality Control
Published in Point of care (01-12-2011)Get full text
Journal Article -
20
Modification of the VerifyNow® P2Y12 test BASE channel to accommodate high levels of P2Y 12 antagonism
Published in Platelets (Edinburgh) (01-12-2011)Get full text
Journal Article